- Home
- SOS vs KZIA Comparison
SOS vs KZIA Comparison
Compare SOS & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOS
- KZIA
- Stock Information
- Founded
- SOS 2004
- KZIA 1994
- Country
- SOS China
- KZIA Australia
- Employees
- SOS N/A
- KZIA N/A
- Industry
- SOS Finance: Consumer Services
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- SOS Finance
- KZIA Health Care
- Exchange
- SOS Nasdaq
- KZIA Nasdaq
- Market Cap
- SOS 10.7M
- KZIA 9.0M
- IPO Year
- SOS 2017
- KZIA 1999
- Fundamental
- Price
- SOS N/A
- KZIA $7.12
- Analyst Decision
- SOS
- KZIA Strong Buy
- Analyst Count
- SOS 0
- KZIA 3
- Target Price
- SOS N/A
- KZIA $16.00
- AVG Volume (30 Days)
- SOS 507.3K
- KZIA 302.5K
- Earning Date
- SOS 09-26-2025
- KZIA 11-14-2025
- Dividend Yield
- SOS N/A
- KZIA N/A
- EPS Growth
- SOS N/A
- KZIA N/A
- EPS
- SOS N/A
- KZIA N/A
- Revenue
- SOS $260,505,000.00
- KZIA $1,549,158.00
- Revenue This Year
- SOS N/A
- KZIA N/A
- Revenue Next Year
- SOS N/A
- KZIA $49.25
- P/E Ratio
- SOS N/A
- KZIA N/A
- Revenue Growth
- SOS 134.43
- KZIA 248983.08
- 52 Week Low
- SOS $1.18
- KZIA $2.86
- 52 Week High
- SOS $2.48
- KZIA $39.05
- Technical
- Relative Strength Index (RSI)
- SOS N/A
- KZIA 44.01
- Support Level
- SOS N/A
- KZIA $6.20
- Resistance Level
- SOS N/A
- KZIA $8.00
- Average True Range (ATR)
- SOS 0.00
- KZIA 0.48
- MACD
- SOS 0.00
- KZIA -0.03
- Stochastic Oscillator
- SOS 0.00
- KZIA 49.73
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.